- This is a great day for Norwegian neuroscience, says Leif Rune Skymoen, CEO of Nansen Neuroscience Network.

NNN member company MentisCura, based in Reykjavik, Iceland, presented new and exciting data at the Alzheimer’s Association International Conference (AAIC) in Copenhagen in July. 


Har du en idé til et nytt produkt eller en ny tjeneste? Delta på Idéprisen og vinn 100 000 kroner! 

Stroke is one of the leading causes of death in the western world. During a stroke, blood flow to parts of the brain is obstructed, followed by a rapid decrease of oxygen and energy supply to the brain tissue. 

During the last days, NNN has been profiling Norwegian neuroscience at the NLSDays in Stockholm. We chaired the neuroscience session, were interviewed by PharmaTelevision, met a range of interesting partners, and had the most visited stand at the conference together with Oslo Cancer Cluster.

We are happy to announce that Innovation Norway have decided to continue supporting the development of NNN. Through an agreement signed in July, Innovation Norway has committed to maintaining NNN’s status as National Innovation Network throughout 2015.

NNN-member Pre Diagnostics was established in 2013 by Erik Christensen and Håkon Sæterøy. The company seeks to develop and commercialize an innovative and very effective diagnostic test for Alzheimer’s disease.

NNN will host an exciting neuroscience session at the Nordic Life Science Days in Stockholm 7.-9. September.